Fillamentum (XPRA:FILL) Research & Development: Kč Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPRA:FILL Fillamentum XPRA:FILL
11 GF Score
Price Kč56.00
! 1 Warning Sign
View Full Analysis

What is Fillamentum Research & Development?

Fillamentum XPRA:FILL 11 Research & Development is Kč Mil as of . 20. GuruFocus rates XPRA:FILL with a GF Score™ of 11/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Fillamentum's Research & Development for the six months ended in . 20 was Kč0.00 Mil. Fillamentum does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

Fillamentum  (XPRA:FILL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Fillamentum Research & Development Related Terms

Fillamentum Research & Development Historical Data

* Premium members only.

The historical data trend for Fillamentum's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fillamentum Research & Development Chart

Fillamentum Annual Data
Trend
Research & Development

Fillamentum Semi-Annual Data
Research & Development
XPRA:FILL
11GF Score
Fillamentum XPRA:FILL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fillamentum Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of Kč Mil mean?
Fillamentum (XPRA:FILL) has a Research & Development of Kč Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on Fillamentum and its competitors.
Is Fillamentum's Research & Development too high?
Fillamentum's current Research & Development is Kč Mil. Overall, Fillamentum has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Fillamentum's Research & Development compare to LIN and SHW?
Fillamentum's Research & Development of Kč Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Chemicals company?
A good Research & Development depends on the Chemicals industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Fillamentum and its competitors. Fillamentum's current Research & Development is Kč Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fillamentum stock overvalued right now?
Fillamentum (XPRA:FILL) has a current Research & Development of Kč Mil. The current Research & Development is Kč Mil. Fillamentum's overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Fillamentum (XPRA:FILL), the current Research & Development is Kč Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Fillamentum Business Description

Address Parzlich s.r.o., Miru 1217, Hulin, CZE, 768 24
Fillamentum manufactures filaments for 3D printing. The product portfolio includes PLA Extra fill Filament, PLA Crystal Clear Filament, CPE filament, Flexfill flexible filament, and others.
11GF Score

Get the complete analysis for XPRA:FILL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Kč56.00
Price